CLINICAL_TRIALS
withdrawal
· 2015-06-11
Clinical Trial Update: Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies [Phase 1, Phase 2]
Summary
A Phase 1/2 trial of Tai-chi / Qi-gong for gynecologic cancers has been withdrawn; the study targeted ovarian cancer and primary peritoneal cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sheba Medical Center | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 1, Phase 2 | Status: WITHDRAWN